Last checked at 10 Nov 2011 09:46
10 November 2011
Advanced Medical Solutions Group plc
("AMS" or "the Company")
Investor site visit
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, will today be hosting a site visit at Winsford for a number of institutional investors.
No new trading or financial information will be disclosed during the visit.
-ends -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc
Chris Meredith, Chief Executive Officer Tel: +44 (0) 1606 545508
Mary Tavener, Finance Director
Tavistock Communications
John West / Chris Munden / Andrew Dunn Tel: +44 (0) 20 7920 3150
Investec Bank plc
Gary Clarence / Daniel Adams Tel: +44 (0) 20 7597 5970
Notes to Editors:
About Advanced Medical Solutions Group plc - see www.admedsol.com
Founded in 1991, AMS is a leading company in the development and manufacture of innovative and technologically advanced products for the US$15 billion global wound care market. These products are sold in countries across the globe either directly or through a number of strategic partners and distributors.
AMS' advanced woundcare products are based on an extensive range of technologies including alginates, silver alginates and hydrophilic polyurethane foams. These and other products pioneer the concept of moist wound healing, allowing wounds to heal faster and with less pain and scarring. They protect the wound, deal with tissue fluids, provide an optimal environment for healing to occur and, in the case of silver alginates, include a safe and effective broad-spectrum anti-microbial agent for infection control.
AMS' wound closure and sealants products are based on cyanoacrylate adhesive ("superglue") technology developed for medical applications. Tissue adhesives offer significant benefits over conventional ways of closing wounds following trauma or surgical incision. They are simple to use, non-invasive, help to reduce the risk of infection, minimise trauma to the patient and provide good clinical and cosmetic outcomes. The technology is also ideally suited to protecting skin from breakdown or for use as a skin sealant to help prevent infection of surgical sites.